Every major ESG fund is about to discover they've been valuing dying assets as productive investments.
Last week, in a room full of ministers, scientists, and financial strategists in Frascati, Rome, I introduced the BIOSENESCENCE framework. The framework reveals systematic gaps in how biological assets are currently valued. Gaps that represent both portfolio risk and strategic opportunity.